U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
USPH on NYSE
Shares outstanding
15,234,314
Price per share
$78.09
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
16,024,919
Total reported value
$1,361,025,879
% of total 13F portfolios
0%
Share change
+431,715
Value change
+$38,772,434
Number of holders
242
Price from insider filings
$78.09
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% $166,938,521 2,162,136 BlackRock, Inc. 30 Jun 2025
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 9.8% +61% $125,550,633 +$46,550,234 1,486,334 +59% Kayne Anderson Rudnick Investment Management, LLC 30 Jun 2025
MORGAN STANLEY 5.9% $62,799,970 889,644 Morgan Stanley 31 Dec 2024
Copeland Capital Management, LLC 5.5% -5.2% $71,696,186 +$14,202,451 843,981 +25% Copeland Capital Management, LLC 30 Sep 2025
As of 30 Sep 2025, U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) has 242 institutional shareholders filing 13F forms. They hold 16,024,919 shares. .

Top 25 institutional shareholders own 84% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 2,177,623 -2.3% 0% $184,989,033
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 8.9% 1,353,357 -9% 0.28% $114,967,760
MORGAN STANLEY 7.4% 1,132,817 +8.1% 0.01% $96,232,971
VANGUARD GROUP INC 7% 1,069,624 -0.43% 0% $90,864,560
Copeland Capital Management, LLC 5.5% 843,981 -5% 1.5% $71,696,293
STATE STREET CORP 4.3% 654,535 +0.63% 0% $55,602,748
SOUTHERNSUN ASSET MANAGEMENT, LLC 3.3% 505,222 -0.52% 5.6% $42,918,609
Boston Trust Walden Corp 3.2% 490,068 -1.6% 0.31% $41,631,276
BAHL & GAYNOR INC 3.1% 474,688 +48% 0.2% $40,324,746
DIMENSIONAL FUND ADVISORS LP 3.1% 474,244 +6.2% 0.01% $40,285,082
GEODE CAPITAL MANAGEMENT, LLC 2.3% 354,140 +0.34% 0% $30,088,609
GW&K Investment Management, LLC 2.3% 350,881 -16% 0.26% $29,807,000
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.3% 345,859 0.08% $29,380,722
Rockefeller Capital Management L.P. 2.2% 340,812 +0.67% 0.06% $28,952,038
ENVESTNET ASSET MANAGEMENT INC 2.2% 337,208 -2.6% 0.01% $28,645,831
BANK OF AMERICA CORP /DE/ 2.1% 317,200 +77% 0% $26,946,137
AMERICAN CENTURY COMPANIES INC 1.7% 258,265 0.01% $21,939,820
SCHRODER INVESTMENT MANAGEMENT GROUP 1.6% 249,635 -35% 0.02% $20,844,523
NORTHERN TRUST CORP 1.5% 229,743 -2.3% 0% $19,516,667
WELLS FARGO & COMPANY/MN 1.1% 164,389 -6.4% 0% $13,964,886
FMR LLC 1% 153,674 -7.3% 0% $13,054,604
CRAWFORD INVESTMENT COUNSEL INC 0.96% 146,752 +7.4% 0.21% $12,466,545
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.94% 142,681 +2.6% 0% $12,120,751
Bank of New York Mellon Corp 0.82% 125,214 -4.8% 0% $10,636,912
Point72 Asset Management, L.P. 0.81% 123,026 -55% 0.02% $10,451,056

Institutional Holders of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 30,746 $2,414,104 -$317,177 $78.09 8
2025 Q3 16,024,919 $1,361,025,879 +$38,772,434 $84.95 242
2025 Q2 15,603,030 $1,220,358,295 +$28,781,344 $78.20 239
2025 Q1 15,293,795 $1,107,121,680 -$19,791,951 $72.36 252
2024 Q4 15,564,672 $1,380,993,867 +$13,759,675 $88.71 254
2024 Q3 15,414,867 $1,304,183,186 +$16,665,613 $84.63 253
2024 Q2 15,173,944 $1,402,410,431 -$59,092,933 $92.42 240
2024 Q1 15,618,754 $1,762,911,090 +$15,312,898 $112.87 234
2023 Q4 20,600 $1,918,684 -$113,072 $93.14 2
2023 Q3 15,398,086 $1,412,523,347 +$3,257,150 $91.73 216
2023 Q2 15,230,274 $1,847,955,681 +$186,392,943 $121.39 209
2023 Q1 13,529,497 $1,324,900,087 +$28,989,271 $97.91 192
2022 Q4 13,431,135 $1,088,370,647 +$72,772,647 $81.03 193
2022 Q3 13,089,928 $995,526,231 -$73,403,750 $76.02 185
2022 Q2 13,042,508 $1,423,973,455 +$34,774,136 $109.20 203
2022 Q1 12,664,191 $1,258,279,835 +$9,423,376 $99.45 202
2021 Q4 12,572,654 $1,201,889,483 -$13,511,928 $95.55 201
2021 Q3 12,685,058 $1,403,959,486 -$4,935,697 $110.60 205
2021 Q2 12,591,039 $1,459,005,128 +$11,454,610 $115.87 213
2021 Q1 12,396,207 $1,290,801,414 -$18,324,171 $104.10 203
2020 Q4 12,753,720 $1,533,894,218 -$23,337,257 $120.25 196
2020 Q3 12,950,670 $1,125,059,401 -$46,831,474 $86.88 174
2020 Q2 11,303,347 $915,450,503 +$15,454,138 $81.02 176
2020 Q1 11,117,897 $767,165,121 +$15,718,694 $69.00 187
2019 Q4 12,842,411 $1,468,352,610 -$43,568,182 $114.35 204
2019 Q3 13,160,686 $1,718,027,320 +$758,280 $130.55 213
2019 Q2 13,157,653 $1,612,808,820 +$13,078,087 $122.57 206
2019 Q1 13,137,500 $1,380,129,290 +$18,544,870 $105.03 211
2018 Q4 12,953,676 $1,325,224,503 +$33,980,194 $102.35 188
2018 Q3 12,629,153 $1,497,641,136 +$23,050,554 $118.60 188
2018 Q2 12,442,790 $1,194,510,484 +$29,015,860 $96.00 176
2018 Q1 12,183,748 $990,712,036 +$21,949,969 $81.30 167
2017 Q4 11,909,571 $859,905,117 +$8,976,381 $72.20 159
2017 Q3 11,860,056 $728,879,542 -$8,511,213 $61.45 164
2017 Q2 11,797,559 $712,645,733 -$1,743,419 $60.40 168
2017 Q1 11,857,601 $774,329,470 +$123,027,276 $65.30 174
2016 Q4 12,088,603 $847,383,561 +$31,804,530 $70.20 168
2016 Q3 11,703,488 $733,763,495 -$2,117,860 $62.70 170
2016 Q2 11,675,871 $702,998,990 -$1,031,958 $60.21 163
2016 Q1 11,559,524 $574,858,968 -$29,744,491 $49.73 146
2015 Q4 12,292,177 $659,315,574 +$31,228,733 $53.68 139
2015 Q3 11,541,393 $518,644,618 +$6,091,965 $44.89 129
2015 Q2 10,390,927 $566,892,209 +$16,367,598 $54.76 127
2015 Q1 11,314,474 $537,129,637 +$6,340,430 $47.50 126
2014 Q4 11,244,101 $471,661,219 +$2,838,607 $41.96 124
2014 Q3 11,221,457 $397,119,203 +$5,215,373 $35.39 111
2014 Q2 11,017,718 $376,917,986 -$697,813 $34.19 104
2014 Q1 11,074,925 $382,192,809 +$4,067,877 $34.57 105